LanzaTech Global, Inc. Liquidation Value

LNZA Chemicals

Cash & Equivalents

$13.16M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $13.16M
Total Obligations: -$44.11M
$-30.95M
Per share: $-13.34
Period: 2025-12-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $13.16M
AR: $6.54M
Total Obligations: -$44.11M
$-24.41M
Per share: $-10.52
Period: 2025-12-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $13.16M
AR: $6.54M
Inventory: $684,000
Total Obligations: -$44.11M
$-23.72M
Per share: $-10.22
Period: 2025-12-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-30.95M$-13.34
Liquid Liquidation Value$-24.41M$-10.52
Operating Liquidation Value$-23.72M$-10.22

Key Components (as of 2025-12-31)

Data as of 2025-12-31 from 10-K filed 2026-03-31. View on SEC EDGAR →

Cash & Equivalents$13.16M
Accounts Receivable$6.54M
Inventory$684,000
Current Liabilities$27.72M
Long-term Debt (?)N/A
Op. Lease Liability (?)$16.39M
Finance Lease (?)N/A
Shares Outstanding2.3M

Explore all 188 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$13.16M$6.54M$684,000$10.87M$27.72MN/A$16.39MN/A
2025-09-30$19.63M$9.34MN/A$6.20M$24.84MN/A$16.53MN/A
2025-06-30$37.37M$8.02MN/A$3.94M$55.82MN/A$16.64MN/A
2025-03-31$13.78M$13.27MN/A$6.43M$26.52MN/A$30.14MN/A
2024-12-31$43.50M$18.98M$2.16M$5.29M$30.45MN/A$30.62MN/A
2024-09-30$58.74M$19.14MN/A$3.12M$46.92MN/A$28.81MN/A
2024-06-30$62.19M$27.09MN/A$4.01M$28.39M$9.25M$29.23MN/A
2024-03-31$56.75M$29.16MN/A$2.07M$21.32M$15.47M$19.33MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-31 View
2025-09-30 10-Q 2025-11-19 View
2025-06-30 10-Q 2025-08-19 View
2025-03-31 10-Q 2025-05-19 View
2024-12-31 10-K 2025-04-15 View
2024-12-31 10-K/A 2025-04-30 View
2024-09-30 10-Q 2024-11-08 View
2024-06-30 10-Q 2024-08-08 View

AI Insights

AI Insight·Generated 2026-05-05

LanzaTech Global, Inc. (LNZA) presents a deeply negative liquidation recovery posture as of December 31, 2025. Total assets of $100.2M are offset by total liabilities of $90.9M at face value, leaving GAAP book equity of negative $3.9M before applying liquidation haircuts. Under the liquidation lens, the recovery deteriorates materially further.

Asset-side analysis: Cash and restricted cash total $17.1M (recoverable at ~100%, yielding ~$17.1M). Accounts receivable net of allowance is approximately $9.5M gross with a $3.0M allowance already recorded; applying a 90% recovery rate to the net figure yields ~$8.6M. Contract assets of $6.5M carry inherent execution-contingent collection risk; recovery haircut to 80% yields ~$5.2M. Inventory of $0.7M at 60% recovery yields ~$0.4M. PP&E gross of $58.0M less accumulated depreciation of $40.9M produces net book value of $17.1M; at a 50-60% recovery rate yields ~$8.6-10.3M. Operating lease ROU asset of $14.4M is a contractual asset with no independent liquidation value and should be assigned zero recovery. Equity method investment in LanzaJet of $13.3M and equity securities without readily determinable fair value of $15.0M are illiquid minority stakes; the LanzaJet investment carries near-zero off-balance-sheet accumulated losses and a restructured governance structure post the February 2026 Series A transaction—recovery is speculative and assigned zero under a forced liquidation scenario. Other current assets ($10.5M) and prepaid expenses ($2.1M) yield partial recovery; applying 50% conservatively adds ~$6.3M. Total liquidation asset recovery is estimated in the range of $46-48M.

Liability side at face value: Total liabilities of $90.9M include operating lease liability $16.6M (does not extinguish on winding up—landlord claims remain), accrued liabilities $10.3M, accounts payable $10.9M, employee-related liabilities $1.8M, deferred revenue current $0.4M and noncurrent $5.9M, derivative liabilities current $4.1M and noncurrent $30.0M (Brookfield Loan FVO liability and PIPE Warrant), and long-term loan payable $10.9M (Brookfield Loan residual). The derivative/Brookfield complex represents a structured liability that would need to be settled or negotiated at effective face value in liquidation.

Conclusion: Estimated liquidation recovery to equity is negative, approximately ($43-45M) before considering the $13.2M Series A preferred stock (mezzanine equity, senior to common), which further subordinates common equity recovery. This is consistent with MFFAIS-reported CLV of negative $30.9M and OLV of negative $23.7M. The accumulated deficit stands at $1.018B. Persistent going concern indicators from the prior 10-Q (as of September 30, 2025 filing) have been partially mitigated by the January 2026 $20M private placement and preferred stock conversion, but these occurred post period-end and are not reflected in the December 31, 2025 balance sheet. Unremediated material weaknesses across multiple COSO framework components were disclosed and persist from the prior filing, adding uncertainty to balance-sheet reliability.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...